Expression, purification, and bioactivity of a soluble recombinant ovine interferon-tau in Escherichia coli

1Alexenko A.P., Ealy A.D., Roberts R.M.: The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential. J Interferon Cytokine Res 1999, 19, 1335–1341, doi: 10.1089/107999099312795.Alexenko A.P. Ealy A.D. Roberts R.M. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential J Interferon Cytokine Res 1999 19 1335 1341 10.1089/107999099312795Open DOISearch in Google Scholar

2Armstrong J.A.: Cytopathic effect inhibition assay for interferon: microculture plate assay. Methods Enzymol 1981, 78, 381–387, doi: 10.1016/0076-6879(81)78145-x.Armstrong J.A. Cytopathic effect inhibition assay for interferon: microculture plate assay Methods Enzymol 1981 78 381 387 10.1016/0076-6879(81)78145-xOpen DOISearch in Google Scholar

3Commission of Chinese Veterinary Pharmacopoeia:. Veterinary Pharmacopeia of the People’s Republic of China, 2010 edition. China Agriculture Press, Beijing. 2010, Part I, Appendix 26–130.Commission of Chinese Veterinary Pharmacopoeia:. Veterinary Pharmacopeia of the People’s Republic of China, 2010 edition China Agriculture Press Beijing 2010 Part I, Appendix 26–130Search in Google Scholar

4Demmers K.J., Derecka K., Flint A.: Trophoblast interferon and pregnancy. Reproduction 2001, 121, 41–49, doi: 10.1530/rep.0.1210041.Demmers K.J. Derecka K. Flint A. Trophoblast interferon and pregnancy Reproduction 2001 121 41 49 10.1530/rep.0.1210041Open DOISearch in Google Scholar

5Isaacs A., Lindenmann J.: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147, 258–267, doi: 10.1098/rspb.1957.0048.Isaacs A. Lindenmann J. Virus interference I. The interferon. Proc R Soc Lond B Biol Sci 1957 147 258 267 10.1098/rspb.1957.0048Open DOISearch in Google Scholar

6Jeannin P., Duluc D., Delneste Y.: IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-gamma. Immunother 2011, 3, 23–26, doi: 10.2217/imt.11.30.Jeannin P. Duluc D. Delneste Y. IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-gamma Immunother 2011 3 23 26 10.2217/imt.11.30Open DOISearch in Google Scholar

7Johnson J.A., Hochkeppel H.K., Gangemi J.D.: IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression. J Interferon Cytokine Res 1999, 19, 1107–1116.Johnson J.A. Hochkeppel H.K. Gangemi J.D. IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression J Interferon Cytokine Res 1999 19 1107 111610.1089/107999099313046Search in Google Scholar

8Juste R.A., Ott T.L., Kwang J., Bazer F.W., de la Concha-Bermejillo A.: Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J Gen Virol 2000, 81, 525–532, doi: 10.1099/0022-1317-81-2-525.Juste R.A. Ott T.L. Kwang J. Bazer F.W. de la Concha-Bermejillo A. Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease J Gen Virol 2000 81 525 532 10.1099/0022-1317-81-2-525Open DOISearch in Google Scholar

9Khan O.A., Jiang H., Subramanian P.S., Johnson H.M., Dhib-Jalbut S.S.: Immunomodulating functions of recombinant ovine interferon tau: potential for therapy in multiple sclerosis and autoimmune disorders. Mult Scler 1998, 4, 63–69, doi: 10.1177/135245859800400204.Khan O.A. Jiang H. Subramanian P.S. Johnson H.M. Dhib-Jalbut S.S. Immunomodulating functions of recombinant ovine interferon tau: potential for therapy in multiple sclerosis and autoimmune disorders Mult Scler 1998 4 63 69 10.1177/135245859800400204Open DOISearch in Google Scholar

10Kruger N.J.: The Bradford method for protein quantitation. In: Basic Protein and Peptide Protocols, part of Methods in Molecular Biology vol. 32, edited by J.M. Walker, Humana, Totowa, NJ, 1994, pp. 9–15, doi: 10.1385/0-89603-268-X:9.Kruger N.J. The Bradford method for protein quantitation. In: Basic Protein and Peptide Protocols, part of Methods in Molecular Biology vol. 32, edited by J.M. Walker Humana, Totowa, NJ 1994 pp 9 15 10.1385/0-89603-268-X:9Open DOISearch in Google Scholar

11Martal J.L., Chêne N.M., Huynh L.P., L’Haridon R.M., Reinaud P.B., Guillomot M.W., Charlier M.A., Charpigny S.Y.: IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 1998, 80, 755–777, doi: 10.1016/s0300-9084(99)80029-7.Martal J.L. Chêne N.M. Huynh L.P. L’Haridon R.M. Reinaud P.B. Guillomot M.W. Charlier M.A. Charpigny S.Y. IFN-tau: a novel subtype I IFN1 Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 1998 80 755 777 10.1016/s0300-9084(99)80029-7Open DOISearch in Google Scholar

12Ott T.L., Van Heeke G., Johnson H.M., Bazer F.W.: Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-I trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity. J Interferon Res 1991, 11, 357–364, doi: 10.1089/jir.1991.11.357.Ott T.L. Van Heeke G. Johnson H.M. Bazer F.W. Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-I trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity J Interferon Res 1991 11 357 364 10.1089/jir.1991.11.3571800584Open DOISearch in Google Scholar

13Pestka S., Krause C.D., Walter M.R.: Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004, 202, 8–32, doi: 10.1111/j.0105-2896.2004.00204.x.Pestka S. Krause C.D. Walter M.R. Interferons, interferon-like cytokines, and their receptors Immunol Rev 2004 202 8 32 10.1111/j.0105-2896.2004.00204.x15546383Open DOISearch in Google Scholar

14Pitha P.M., Kunzi M.S.: Type I interferon: The ever unfolding story. Curr Top Microbiol 2007, 316, 41–70, doi: 10.1007/978-3540-71329-6_4.Pitha P.M. Kunzi M.S. Type I interferon: The ever unfolding story Curr Top Microbiol 2007 316 41 70 10.1007/978-3540-71329-6_4Open DOISearch in Google Scholar

15Pontzer C.H., Yamamoto J.K., Bazer F.W., Ott T.L., Johnson H.M.: Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau. J Immunol 1997, 158, 4351–4357.Pontzer C.H. Yamamoto J.K. Bazer F.W. Ott T.L. Johnson H.M. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau J Immunol 1997 158 4351 435710.4049/jimmunol.158.9.4351Search in Google Scholar

16Reed L.J., Muench H.: A simple method of estimating 50 percent end points. Am J Hyg 1938, 27, 493–497, doi: 10.1093/oxfordjournals.aje.a118408.Reed L.J. Muench H. A simple method of estimating 50 percent end points Am J Hyg 1938 27 493 497 10.1093/oxfordjournals.aje.a118408Open DOISearch in Google Scholar

17Rogez C., Martin M., Dereuddre-Bosquet N., Martal J., Dormont D., Clayette P.: Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines. J Virol 2003, 77, 12914–12920, doi: 10.1128/JVI.77.23.12914-12920.2003.Rogez C. Martin M. Dereuddre-Bosquet N. Martal J. Dormont D. Clayette P. Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines J Virol 2003 77 12914 12920 10.1128/JVI.77.23.12914-12920.200326257014610214Open DOISearch in Google Scholar

18Rubinstein S., Familletti P.C., Pestka S.: Convenient assay for interferons. J Virol 1981, 37, 755–758, doi: 10.1128/JVI.37.2.755-758.1981.Rubinstein S. Familletti P.C. Pestka S. Convenient assay for interferons J Virol 1981 37 755 758 10.1128/JVI.37.2.755-758.19811710636163873Open DOISearch in Google Scholar

19Samuel C.E.: Antiviral actions of interferons. Clin Microbiol Rev 2001, 14, 778–809, doi: 10.1128/CMR.14.4.778-809.2001.Samuel C.E. Antiviral actions of interferons Clin Microbiol Rev 2001 14 778 809 10.1128/CMR.14.4.778-809.20018900311585785Open DOISearch in Google Scholar

20Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M.: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003, 4, 63–68, doi: 10.1038/ni873.Sheppard P. Kindsvogel W. Xu W. Henderson K. Schlutsmeyer S. Whitmore T.E. Kuestner R. Garrigues U. Birks C. Roraback J. Ostrander C. Dong D. Shin J. Presnell S. Fox B. Haldeman B. Cooper E. Taft D. Gilbert T. Grant F.J. Tackett M. Krivan W. McKnight G. Clegg C. Foster D. Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 2003 4 63 68 10.1038/ni87312469119Open DOISearch in Google Scholar

21Sinha J., Plantz B.A., Zhang W., Gouthro M., Schlegel V., Liu C.P., Meagher M.M.: Improved production of recombinant ovine interferon-tau by mut(+) strain of Pichia pastoris using an optimized methanol feed profile. Biotechnol Prog 2003, 19, 794–802, doi: 10.1021/bp025744q.Sinha J. Plantz B.A. Zhang W. Gouthro M. Schlegel V. Liu C.P. Meagher M.M. Improved production of recombinant ovine interferon-tau by mut(+) strain of Pichia pastoris using an optimized methanol feed profile Biotechnol Prog 2003 19 794 802 10.1021/bp025744q12790641Open DOISearch in Google Scholar

22Soos J.M., Johnson H.M.: Interferon-tau: prospects for clinical use in autoimmune disorders. BioDrugs 1999, 11, 125–135, doi: 10.2165/00063030-199911020-00006.Soos J.M. Johnson H.M. Interferon-tau: prospects for clinical use in autoimmune disorders BioDrugs 1999 11 125 135 10.2165/00063030-199911020-0000618031121Open DOISearch in Google Scholar

23Taylor K.E., Mossman K.L.: Recent advances in understanding viral evasion of type I interferon. Immunology 2013, 138, 190–197, doi: 10.1111/imm.12038.Taylor K.E. Mossman K.L. Recent advances in understanding viral evasion of type I interferon Immunology 2013 138 190 197 10.1111/imm.12038357327223173987Open DOISearch in Google Scholar

24Tian L., Zhao P., Ma B., Guo G., Sun Y., Xing M-W.: Cloning, expression and antiviral bioactivity of red-crowned crane interferon-alpha. Gene 2014, 544, 49–55, doi: 10.1016/j.gene.2014.04.036.Tian L. Zhao P. Ma B. Guo G. Sun Y. Xing M-W. Cloning, expression and antiviral bioactivity of red-crowned crane interferon-alpha Gene 2014 544 49 55 10.1016/j.gene.2014.04.03624768181Open DOISearch in Google Scholar

25Todt D., Francois C., Anggakusuma., Behrendt P., Engelmann M., Knegendorf L., Vieyres G., Wedemeyer H., Hartmann R., Pietschmann T., Duverlie G., Steinmann E.: Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication. Antimicrob Agents Chemother 2016, 60, 2132–2139, doi: 10.1128/aac.02427-15.Todt D. Francois C. Anggakusuma. Behrendt P. Engelmann M. Knegendorf L. Vieyres G. Wedemeyer H. Hartmann R. Pietschmann T. Duverlie G. Steinmann E. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication Antimicrob Agents Chemother 2016 60 2132 2139 10.1128/aac.02427-15Open DOISearch in Google Scholar

26Usharani J., Park S.Y., Cho E-J., Kim C., Ko Y-J., Tark D., Kim S-M., Park J-H., Lee K-N., Lee M-H., Lee H-S.: Antiviral activity of ovine interferon tau 4 against foot-and-mouth disease virus. Antiviral Res 2017, 143, 134–141, doi: 10.1016/j.antiviral.2017.01.018.Usharani J. Park S.Y. Cho E-J. Kim C. Ko Y-J. Tark D. Kim S-M. Park J-H. Lee K-N. Lee M-H. Lee H-S. Antiviral activity of ovine interferon tau 4 against foot-and-mouth disease virus Antiviral Res 2017 143 134 141 10.1016/j.antiviral.2017.01.01828137623Open DOISearch in Google Scholar

27Van Heeke G., Ott T.L., Strauss A., Ammaturo D., Bazer F.W.: High yield expression and secretion of the ovine pregnancy recognition hormone interferon-tau by Pichia pastoris. J Interferon Cytokine Res 1996, 16, 119–126, doi: 10.1089/jir.1996.16.119.Van Heeke G. Ott T.L. Strauss A. Ammaturo D. Bazer F.W. High yield expression and secretion of the ovine pregnancy recognition hormone interferon-tau by Pichia pastoris J Interferon Cytokine Res 1996 16 119 126 10.1089/jir.1996.16.1198742364Open DOISearch in Google Scholar